1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThe NIAMS SBIR program funds U. S. small businesses developing innovative research with commercialization potential in NIAMS's core disease domains: arthritis and rheumatic diseases, musculoskeletal and bone disorders, and skin conditions.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: U. S. small businesses developing innovative research with commercialization potential in arthritis and rheumatic diseases, musculoskeletal and bone disorders, and skin conditions. Confirm the full requirements in the official notice before applying.
NIAMS SBIR (R43/R44) is funded by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) is sponsored by National Institutes of Health (NIH) (Participating Organizations include NIAID, NIAMS, NIDA, NIEHS, NIMHD). This is a parent funding opportunity for the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Commercialization Readiness Pilot (CRP) Program. It supports the commercialization of research and development conducted by small businesses.
Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to accelerate translation and/or commercialization of musculoskeletal and skin tissue engineering and regenerative medicine research is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) - NIH. Solicits SBIR grant applications from small business concerns (SBCs) that propose to accelerate translation and/or commercialization of musculoskeletal and skin tissue engineering and regenerative medicine research. The focus is on pre-clinical studies with potential to immediately lead to phase I human clinical trials, or on development of pre-clinical animal models to assess safety and efficacy of potential commercial products.